These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17273925)

  • 1. Shooting gallery operation in the context of establishing a medically supervised injecting center: Sydney, Australia.
    Kimber J; Dolan K
    J Urban Health; 2007 Mar; 84(2):255-66. PubMed ID: 17273925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?
    Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L
    Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
    Salmon AM; van Beek I; Amin J; Kaldor J; Maher L
    Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental health among clients of the Sydney Medically Supervised Injecting Centre (MSIC).
    Goodhew M; Salmon AM; Marel C; Mills KL; Jauncey M
    Harm Reduct J; 2016 Oct; 13(1):29. PubMed ID: 27733167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime.
    Freeman K; Jones CG; Weatherburn DJ; Rutter S; Spooner CJ; Donnelly N
    Drug Alcohol Rev; 2005 Mar; 24(2):173-84. PubMed ID: 16076587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney.
    van Beek I; Gilmour S
    Aust N Z J Public Health; 2000 Oct; 24(5):540-2. PubMed ID: 11109694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre.
    Kimber J; Mattick RP; Kaldor J; van Beek I; Gilmour S; Rance JA
    Drug Alcohol Rev; 2008 Nov; 27(6):602-12. PubMed ID: 19378444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods.
    Kimber J; Hickman M; Degenhardt L; Coulson T; van Beek I
    Addiction; 2008 Oct; 103(10):1604-13. PubMed ID: 18638037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A description of a peer-run supervised injection site for injection drug users.
    Kerr T; Oleson M; Tyndall MW; Montaner J; Wood E
    J Urban Health; 2005 Jun; 82(2):267-75. PubMed ID: 15872193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
    Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
    Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a medically supervised injection facility among street youth.
    Hadland SE; DeBeck K; Kerr T; Nguyen P; Simo A; Montaner JS; Wood E
    J Adolesc Health; 2014 Nov; 55(5):684-9. PubMed ID: 24925493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Sydney Medically Supervised Injecting Centre: a controversial public health measure.
    Kelly C; Conigrave KM
    Aust N Z J Public Health; 2002 Dec; 26(6):552-4. PubMed ID: 12530800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.
    Bouvier BA; Elston B; Hadland SE; Green TC; Marshall BD
    Harm Reduct J; 2017 Feb; 14(1):13. PubMed ID: 28219388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdose Risk and Client Characteristics Associated With the Injection of Buprenorphine at a Medically Supervised Injecting Center in Sydney, Australia.
    Power J; Salmon AM; Latimer J; Jauncey M; Day CA
    Subst Use Misuse; 2019; 54(10):1646-1653. PubMed ID: 30973286
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia.
    Roxburgh A; Livingston M; Dietze P; Nielsen S; Cogger S; Bartlett M; Day C; Latimer J; Jauncey M; Clark N
    Public Health; 2023 Nov; 224():90-97. PubMed ID: 37742585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injecting-related injury and disease among clients of a supervised injecting facility.
    Salmon AM; Dwyer R; Jauncey M; van Beek I; Topp L; Maher L
    Drug Alcohol Depend; 2009 Apr; 101(1-2):132-6. PubMed ID: 19167171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining Overdose and Homelessness as Predictors of Willingness to Use Supervised Injection Facilities by Services Provided Among Persons Who Inject Drugs.
    Kenney SR; Anderson BJ; Bailey GL; Herman DS; Conti MT; Stein MD
    Am J Addict; 2021 Jan; 30(1):21-25. PubMed ID: 32519449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre.
    Salmon AM; van Beek I; Amin J; Grulich A; Maher L
    Aust N Z J Public Health; 2009 Jun; 33(3):280-3. PubMed ID: 19630850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark.
    Kinnard EN; Howe CJ; Kerr T; Skjødt Hass V; Marshall BD
    Harm Reduct J; 2014 Oct; 11(1):29. PubMed ID: 25352296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type.
    Lefrancois E; Belackova V; Silins E; Latimer J; Jauncey M; Shimmon R; Mozaner Bordin D; Augsburger M; Esseiva P; Roux C; Morelato M
    Drug Alcohol Depend; 2020 Apr; 209():107909. PubMed ID: 32145660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.